Categories AlphaGraphs, Earnings, Health Care
Key metrics from Biogen’s (BIIB) Q4 2024 earnings results
Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings results today.
Total revenue increased 3% year-over-year to $2.5 billion.
Net income attributable to Biogen Inc. was $266.8 million, or $1.83 per share, compared to $249.7 million, or $1.71 per share, last year. Adjusted EPS grew 17% YoY to $3.44.
For full-year 2025, the company expects total revenue to decline by a mid-single digit percentage at constant currency versus full-year 2024. Adjusted EPS is expected to be $15.25-16.25.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Important takeaways from Signet Jewelers’ (SIG) Q4 2025 report
Signet Jewelers' (NYSE: SIG) stock rallied in premarket trading on Wednesday after the diamond retailer announced positive financial guidance, despite reporting a decline in fourth-quarter sales and profit. The investor
General Mills (GIS) anticipates macroeconomic headwinds to continue through next quarter
Shares of General Mills, Inc. (NYSE: GIS) were down over 2% on Wednesday after the company delivered mixed results for the third quarter of 2025 and lowered its outlook for
Signet Jewelers (SIG) Q4 2025 Earnings fall on lower sales
Signet Jewelers Limited (NYSE: SIG) on Wednesday reported a decrease in adjusted earnings and net sales for the fourth quarter of 2025. Fourth-quarter sales declined 6% to $2.35 billion from
